Concepedia

A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response

Yuri Masui, Yoshihide Asano, S. Shibata, Shinji Noda, Kaname Akamata, Naohiko Aozasa, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama,

Lara D. Veeken · 2013 · 32 citations · 18 references

Abstract

Visfatin may contribute to the resolution of skin sclerosis in late-stage dcSSc via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.

References

18

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

Alfonse T. Masi · Arthritis & Rheumatism · 1980 · 4.9K citations

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. · 2001 · 4K citations

Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin

Atsunori Fukuhara, Morihiro Matsuda, Masako Nishizawa et al. · Science · 2004 · 1.9K citations

Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties

Alexander R. Moschen, Arthur Kaser, Barbara Enrich et al. · The Journal of Immunology · 2007 · 914 citations · Full text

Pre–B cell colony–enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

Song Jia, Yue Li, Jean Parodo et al. · Journal of Clinical Investigation · 2004 · 594 citations · Full text